JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Choline", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "France", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gallium Isotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gallium Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron Emission Tomography Computed Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostate-Specific Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Direction des m\u00e9dicaments en oncologie, h\u00e9matologie, transplantation, n\u00e9phrologie, th\u00e9rapie cellulaire, produits sanguins, et radiopharmaceutiques, Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (ANSM), 143 Bd Anatole, F93200, St Denis, France", 
          "id": "http://www.grid.ac/institutes/grid.483743.f", 
          "name": [
            "Direction des m\u00e9dicaments en oncologie, h\u00e9matologie, transplantation, n\u00e9phrologie, th\u00e9rapie cellulaire, produits sanguins, et radiopharmaceutiques, Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (ANSM), 143 Bd Anatole, F93200, St Denis, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chevalme", 
        "givenName": "Yanna-Marina", 
        "id": "sg:person.013471630317.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013471630317.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Direction des m\u00e9dicaments en oncologie, h\u00e9matologie, transplantation, n\u00e9phrologie, th\u00e9rapie cellulaire, produits sanguins, et radiopharmaceutiques, Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (ANSM), 143 Bd Anatole, F93200, St Denis, France", 
          "id": "http://www.grid.ac/institutes/grid.483743.f", 
          "name": [
            "Direction des m\u00e9dicaments en oncologie, h\u00e9matologie, transplantation, n\u00e9phrologie, th\u00e9rapie cellulaire, produits sanguins, et radiopharmaceutiques, Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9 (ANSM), 143 Bd Anatole, F93200, St Denis, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boudali", 
        "givenName": "Lotfi", 
        "id": "sg:person.012314332345.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012314332345.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de m\u00e9decine nucl\u00e9aire, H\u00f4pital Tenon, AP-HP Sorbonne Universit\u00e9, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413483.9", 
          "name": [
            "Service de m\u00e9decine nucl\u00e9aire, H\u00f4pital Tenon, AP-HP Sorbonne Universit\u00e9, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gauth\u00e9", 
        "givenName": "Mathieu", 
        "id": "sg:person.01121730347.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121730347.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Unit, ICO Ren\u00e9 Gauducheau, CNRS, Inserm, CRCINA, Nantes University, F-44000, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.4817.a", 
          "name": [
            "Nuclear Medicine Unit, ICO Ren\u00e9 Gauducheau, CNRS, Inserm, CRCINA, Nantes University, F-44000, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rousseau", 
        "givenName": "Caroline", 
        "id": "sg:person.01240530667.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240530667.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Department, Hospices Civils de Lyon, EA 3738, Universit\u00e9 Claude Bernard Lyon 1, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413852.9", 
          "name": [
            "Nuclear Medicine Department, Hospices Civils de Lyon, EA 3738, Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Skanjeti", 
        "givenName": "Andrea", 
        "id": "sg:person.01203037034.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203037034.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Department, Cancer Center Jean PERRIN, Clermont-Ferrand, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Nuclear Medicine Department, Cancer Center Jean PERRIN, Clermont-Ferrand, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Merlin", 
        "givenName": "Charles", 
        "id": "sg:person.0636003365.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636003365.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de M\u00e9decine Nucl\u00e9aire, EA 3878 (GETBO), Centre Hospitalier R\u00e9gional et Universitaire de Brest, Universit\u00e9 de Bretagne Occidentale, Brest, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Service de M\u00e9decine Nucl\u00e9aire, EA 3878 (GETBO), Centre Hospitalier R\u00e9gional et Universitaire de Brest, Universit\u00e9 de Bretagne Occidentale, Brest, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Robin", 
        "givenName": "Philippe", 
        "id": "sg:person.01307140060.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307140060.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Department LUMEN, L\u00e9on B\u00e9rard Cancer Center, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.462282.8", 
          "name": [
            "Nuclear Medicine Department LUMEN, L\u00e9on B\u00e9rard Cancer Center, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giraudet", 
        "givenName": "Anne-Laure", 
        "id": "sg:person.0760027635.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760027635.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Comit\u00e9 permanent de l\u2019ANSM, M\u00e9dicaments de diagnostic et de m\u00e9decine nucl\u00e9aire, St Denis, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Nuclear Medicine Department, Hospices Civils de Lyon, EA 3738, Universit\u00e9 Claude Bernard Lyon 1, Lyon, France", 
            "Comit\u00e9 permanent de l\u2019ANSM, M\u00e9dicaments de diagnostic et de m\u00e9decine nucl\u00e9aire, St Denis, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Janier", 
        "givenName": "Marc", 
        "id": "sg:person.0577012270.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577012270.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Comit\u00e9 permanent de l\u2019ANSM, M\u00e9dicaments de diagnostic et de m\u00e9decine nucl\u00e9aire, St Denis, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Service de m\u00e9decine nucl\u00e9aire, H\u00f4pital Tenon, AP-HP Sorbonne Universit\u00e9, Paris, France", 
            "Comit\u00e9 permanent de l\u2019ANSM, M\u00e9dicaments de diagnostic et de m\u00e9decine nucl\u00e9aire, St Denis, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Talbot", 
        "givenName": "Jean-No\u00ebl", 
        "id": "sg:person.07715603712.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07715603712.83"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00259-019-04548-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1122256860", 
          "https://doi.org/10.1007/s00259-019-04548-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-017-3711-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085391295", 
          "https://doi.org/10.1007/s00259-017-3711-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-017-3670-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084020155", 
          "https://doi.org/10.1007/s00259-017-3670-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-016-3578-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002221535", 
          "https://doi.org/10.1007/s00259-016-3578-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-013-2525-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010481232", 
          "https://doi.org/10.1007/s00259-013-2525-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-019-04505-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1120901331", 
          "https://doi.org/10.1007/s00259-019-04505-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-020-04718-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1125547439", 
          "https://doi.org/10.1007/s00259-020-04718-w"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13550-020-0595-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1124553996", 
          "https://doi.org/10.1186/s13550-020-0595-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-015-3240-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020308992", 
          "https://doi.org/10.1007/s00259-015-3240-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-018-4189-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1107767706", 
          "https://doi.org/10.1007/s00259-018-4189-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-018-4067-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104899563", 
          "https://doi.org/10.1007/s00259-018-4067-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-020-04809-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1126836112", 
          "https://doi.org/10.1007/s00259-020-04809-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-01-08", 
    "datePublishedReg": "2021-01-08", 
    "description": "IntroductionDespite growing evidence of a superior diagnostic performance of 68Ga-PSMA-11 over 18F-fluorocholine (FCH) PET/CT, the number of PET/CT centres able to label on site with gallium-68 is still currently limited. Therefore, patients with biochemical recurrence (BCR) of prostate cancer frequently undergo FCH as the 1st-line PET/CT. Actually, the positivity rate (PR) of a second-line PSMA-11 PET/CT in case of negative FCH PET/CT has only been reported in few short series, in a total of 185 patients. Our aims were to check (1) whether the excellent PR reported with PSMA-11 is also obtained in BCR patients whose recent FCH PET/CT was negative or equivocal; (2) in which biochemical and clinical context a high PSMA-11 PET/CT PR may be expected in those patients, in particular revealing an oligometastatic pattern; (3) whether among the various imaging protocols for PSMA-11 PET/CT used in France, one yields a significantly highest PR; (4) the tolerance of PSMA-11.Patients and methodsSix centres performed 68Ga-PSMA-11 PET/CTs during the first 3 years of its use in France. Prior to each PET/CT, the patient\u2019s data were submitted prospectively for authorisation to ANSM, the French Medicine Agency. The on-site readings of 1084 PSMA-11 PET/CTs in BCR patients whose recent FCH PET/CTs resulted negative or equivocal were pooled and analysed.Results(1) The overall PR was 68%; for a median serum PSA level (sPSA) of 1.7 ng/mL, an oligometastatic pattern (1\u20133 foci) was observed in 31% of the cases overall; (2) PR was significantly related to sPSA (from 41% if < 0.2 ng/mL to 81% if \u2265 2 ng/mL), to patients\u2019 age, to initial therapy (64% if prostatectomy vs. 85% without prostatectomy due to frequent foci in the prostate fossa), to whether FCH PET/CT was negative or equivocal (PR = 62% vs. 82%), and to previous BCR (PR = 63% for 1st BCR vs. 72% in case of previous BCR); (3) no significant difference in PR was found according to the imaging protocol: injected activity, administration of a contrast agent and/or of furosemide, dose length product, one single or multiple time points of image acquisition; (4) no adverse event was reported after PSMA-11 injection, even associated with a contrast agent and/or furosemide.ConclusionCompared with the performance of PSMA-11 PET/CT in BCR reported independently of FCH PET/CT in 6 large published series (n > 200), the selection based on FCH PET/CT resulted in no difference of PSMA-11 PR for sPSA < 1 ng/mL but in a slightly lower PR for sPSA \u2265 1 ng/mL, probably because FCH performs rather well at this sPSA and very occult BCR was over-represented in our cohort. An oligometastatic pattern paving the way to targeted therapy was observed in one fourth to one third of the cases, according to the clinico-biochemical context of the BCR. Systematic dual or triple acquisition time points or administration of a contrast agent and/or furosemide did not bring a significant added value for PSMA-11 PET/CT positivity and should be decided on individual bases.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00259-020-05086-1", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "48"
      }
    ], 
    "keywords": [
      "FCH PET/CT", 
      "PSMA-11 PET/CT", 
      "serum PSA levels", 
      "PET/CT", 
      "biochemical recurrence", 
      "positivity rate", 
      "French Medicines Agency", 
      "prostate cancer", 
      "BCR patients", 
      "Medicines Agency", 
      "median serum PSA level", 
      "PET/CT positivity", 
      "overall positivity rate", 
      "time points", 
      "CT positivity rate", 
      "imaging protocol", 
      "higher positivity rate", 
      "dose-length product", 
      "low positivity rate", 
      "contrast agents", 
      "PSA levels", 
      "initial therapy", 
      "adverse events", 
      "CT positivity", 
      "superior diagnostic performance", 
      "multiple time points", 
      "targeted therapy", 
      "patients", 
      "diagnostic performance", 
      "CT", 
      "line PET/CT", 
      "clinical context", 
      "patient data", 
      "PSMA-11", 
      "furosemide", 
      "length product", 
      "acquisition time points", 
      "recurrence", 
      "significant differences", 
      "individual basis", 
      "cancer", 
      "therapy", 
      "administration", 
      "gallium-68", 
      "detection rate", 
      "site readings", 
      "FCH", 
      "agents", 
      "IntroductionDespite", 
      "short series", 
      "cases", 
      "cohort", 
      "protocol", 
      "positivity", 
      "total", 
      "ANSM", 
      "age", 
      "differences", 
      "injection", 
      "examination", 
      "rate", 
      "third", 
      "safety", 
      "aim", 
      "patterns", 
      "years", 
      "PET", 
      "evidence", 
      "center", 
      "data", 
      "levels", 
      "activity", 
      "image acquisition", 
      "events", 
      "series", 
      "tolerance", 
      "survey", 
      "use", 
      "authorisation", 
      "number", 
      "sites", 
      "France", 
      "point", 
      "agencies", 
      "acquisition", 
      "values", 
      "basis", 
      "context", 
      "selection", 
      "products", 
      "reading", 
      "performance", 
      "way"
    ], 
    "name": "Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal 18F-fluorocholine PET/CT: 1084 examinations", 
    "pagination": "2935-2950", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1134446316"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-020-05086-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33416958"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-020-05086-1", 
      "https://app.dimensions.ai/details/publication/pub.1134446316"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_922.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00259-020-05086-1"
  }
]

Download the RDF metadata as:  json-ld nt turtle xml License info

This table displays all metadata directly associated to this object as RDF triples.

326 TRIPLES      21 PREDICATES      140 URIs      120 LITERALS      17 BLANK NODES